Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Datti

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Plos One|November 23, 2013
RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugsTyler J W Robinson, Jeff C Liu, Frederick Vizeacoumar, et al.
Molecular Systems Biology|November 6, 2009
Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathwayBryan W Miller, Garnet Lau, Chris Grouios, et al.
Cancer Research|February 10, 2011
Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cellsNatalie Grinshtein, Alessandro Datti, Mayumi Fujitani, et al.
Cancer Research|September 7, 2007
A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesisImtiaz A Mawji, Craig D Simpson, Marcela Gronda, et al.
Nucleic Acids Research|October 20, 2011
PhenoM: a database of morphological phenotypes caused by mutation of essential genes in Saccharomyces cerevisiaeKe Jin, Jingjing Li, Frederick S Vizeacoumar, et al.
Journal of Alzheimer'S Disease : JAD|February 16, 2011
Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitusRoberto Tiribuzi, Antonio Orlacchio, Lucia Crispoltoni, et al.
Stem Cell Reports|January 4, 2016
Identification of Drugs that Regulate Dermal Stem Cells and Enhance Skin RepairSibel Naska, Scott A Yuzwa, Adam P W Johnston, et al.
Biomolecules|April 17, 2020
Sorafenib as an Inhibitor of RUVBL2Nardin Nano, Francisca Ugwu, Thiago V Seraphim, et al.
Oncotarget|December 2, 2015
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanismLianne E Rotin, Marcela Gronda, Neil MacLean, et al.
The Journal of Biological Chemistry|November 25, 2020
An endogenous PI3K interactome promoting astrocyte-mediated neuroprotection identifies a novel association with RNA-binding protein ZC3H14Samih Alqawlaq, Izhar Livne-Bar, Declan Williams, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Plos One|November 23, 2013
RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugsTyler J W Robinson, Jeff C Liu, Frederick Vizeacoumar, et al.
Molecular Systems Biology|November 6, 2009
Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathwayBryan W Miller, Garnet Lau, Chris Grouios, et al.
Cancer Research|February 10, 2011
Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cellsNatalie Grinshtein, Alessandro Datti, Mayumi Fujitani, et al.
Cancer Research|September 7, 2007
A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesisImtiaz A Mawji, Craig D Simpson, Marcela Gronda, et al.
Nucleic Acids Research|October 20, 2011
PhenoM: a database of morphological phenotypes caused by mutation of essential genes in Saccharomyces cerevisiaeKe Jin, Jingjing Li, Frederick S Vizeacoumar, et al.
Journal of Alzheimer'S Disease : JAD|February 16, 2011
Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitusRoberto Tiribuzi, Antonio Orlacchio, Lucia Crispoltoni, et al.
Stem Cell Reports|January 4, 2016
Identification of Drugs that Regulate Dermal Stem Cells and Enhance Skin RepairSibel Naska, Scott A Yuzwa, Adam P W Johnston, et al.
Biomolecules|April 17, 2020
Sorafenib as an Inhibitor of RUVBL2Nardin Nano, Francisca Ugwu, Thiago V Seraphim, et al.
Oncotarget|December 2, 2015
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanismLianne E Rotin, Marcela Gronda, Neil MacLean, et al.
The Journal of Biological Chemistry|November 25, 2020
An endogenous PI3K interactome promoting astrocyte-mediated neuroprotection identifies a novel association with RNA-binding protein ZC3H14Samih Alqawlaq, Izhar Livne-Bar, Declan Williams, et al.
Pageof 9